Abstract:E26 transformation-specific fi c translocation variant 5 (ETV5) has been implicated in the pathogenesis of inflammatory fl ammatory bowel diseases (IBD). However, the exact roles of ETV5 in regulating CD4+ + T cell-mediated - mediated intestinal inflammation fl ammation and fi brosis formation remain unclear. Here, we reveal that ETV5 overexpression induced interleukin (IL)-9 and its transcription factor IRF4 expression in IBD CD4+ T cells under T helper type 9 (Th9) cells-polarizing - polarizing conditions. The silencing of IRF4 inhibited ETV5-induced IL-9 expression. CD4+ + cell-specific - speci fi c ETV5 deletion ameliorated intestinal inflammation fl ammation and fi brosis in trinitrobenzene sulfonic acid (TNBS)-induced - induced experimental colitis and CD4+T + T cell-transferred - transferred recombination-activating gene-1 knockout (Rag1-/-) - / - ) colitis mice, characterized by less CD4+ + T cell infiltration fi ltration and lower fi broblast activation and collagen deposition in the colonic tissues. Furthermore, IL-9 treatment aggressive TNBS-induced - induced intestinal fi brosis in CD4+ + T cell-specific - speci fi c ETV5 deletion and wild-type control mice. In vitro, human intestinal fi broblasts cocultured with ETV5 overexpressed-Th9 cells expressed higher levels of collagen I and III, whereas an inclusion of anti-IL-9 antibody could reverse this effect. Ribonucleic acid sequencing analysis demonstrated that IL-9 upregulated TAF1 expression in human intestinal fi broblasts. Clinical data showed that number of alpha-smooth muscle actin+TAF1+ + TAF1 + fi broblasts are higher in inflamed fl amed mucosa of patients with IBD. Importantly, TAF1 small interfering ribonucleic acid treatment suppressed IL9-mediated - mediated profibrotic fi brotic effect in vitro. . These fi ndings reveal that CD4+ + T cell-derived - derived ETV5 promotes intestinal inflammation fl ammation and fi brosis through upregulating IL-9-mediated - mediated intestinal inflammatory fl ammatory and fi brotic response in IBD. Thus, the ETV5/IL-9 signal pathway in T cells might represent a novel therapeutic target for intestinal inflammation fl ammation and fi brosis in IBD.

ETS Translocation Variant 5 (ETV5) Promotes CD4++ T Cell-Mediated - Mediated Intestinal Inflammation Fl Ammation and Fi Brosis in Inflammatory Fl Ammatory Bowel Diseases